Maintaining mental health and function for the long run in cystic fibrosis

Beth A. Smith, Anna M. Georgiopoulos, Alexandra Quittner

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Research shows that individuals with cystic fibrosis (CF) and their families experience significant emotional morbidity. In addition to distress, worry, and grief, high rates of clinically significant symptoms of depression and anxiety have been found in both individuals with CF and parents. These disorders have a major impact on the person's functioning, and that of their family, and adversely impact the capacity to cope with the burden of CF and adhere to prescribed treatments. Despite growing recognition that mental health care is an essential component of comprehensive CF care, evidence suggests many patients and their families do not receive needed support and mental health interventions. Clinical practice guidelines for screening and treating depression and anxiety in individuals with CF have been developed by The Cystic Fibrosis Foundation and the European Cystic Fibrosis Society in response to this need. This review highlights that the optimum care for individuals with CF and their families incorporates mental health in routine CF care. Addressing mental health could substantially improve physical and mental health outcomes and the functioning of individuals with CF and their families. Pediatr Pulmonol. 2016;51:S71–S78.

Original languageEnglish (US)
Pages (from-to)S71-S78
JournalPediatric Pulmonology
Volume51
DOIs
StatePublished - Oct 1 2016

Fingerprint

Cystic Fibrosis
Mental Health
Anxiety
Depression
Grief
Practice Guidelines
Parents
Morbidity
Delivery of Health Care
Research

Keywords

  • anxiety
  • cystic fibrosis
  • depression
  • screening
  • treatment

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pulmonary and Respiratory Medicine

Cite this

Maintaining mental health and function for the long run in cystic fibrosis. / Smith, Beth A.; Georgiopoulos, Anna M.; Quittner, Alexandra.

In: Pediatric Pulmonology, Vol. 51, 01.10.2016, p. S71-S78.

Research output: Contribution to journalReview article

Smith, Beth A. ; Georgiopoulos, Anna M. ; Quittner, Alexandra. / Maintaining mental health and function for the long run in cystic fibrosis. In: Pediatric Pulmonology. 2016 ; Vol. 51. pp. S71-S78.
@article{9061da43cf8a490aa44501f7cd7e8d5e,
title = "Maintaining mental health and function for the long run in cystic fibrosis",
abstract = "Research shows that individuals with cystic fibrosis (CF) and their families experience significant emotional morbidity. In addition to distress, worry, and grief, high rates of clinically significant symptoms of depression and anxiety have been found in both individuals with CF and parents. These disorders have a major impact on the person's functioning, and that of their family, and adversely impact the capacity to cope with the burden of CF and adhere to prescribed treatments. Despite growing recognition that mental health care is an essential component of comprehensive CF care, evidence suggests many patients and their families do not receive needed support and mental health interventions. Clinical practice guidelines for screening and treating depression and anxiety in individuals with CF have been developed by The Cystic Fibrosis Foundation and the European Cystic Fibrosis Society in response to this need. This review highlights that the optimum care for individuals with CF and their families incorporates mental health in routine CF care. Addressing mental health could substantially improve physical and mental health outcomes and the functioning of individuals with CF and their families. Pediatr Pulmonol. 2016;51:S71–S78.",
keywords = "anxiety, cystic fibrosis, depression, screening, treatment",
author = "Smith, {Beth A.} and Georgiopoulos, {Anna M.} and Alexandra Quittner",
year = "2016",
month = "10",
day = "1",
doi = "10.1002/ppul.23522",
language = "English (US)",
volume = "51",
pages = "S71--S78",
journal = "Pediatric Pulmonology",
issn = "8755-6863",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Maintaining mental health and function for the long run in cystic fibrosis

AU - Smith, Beth A.

AU - Georgiopoulos, Anna M.

AU - Quittner, Alexandra

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Research shows that individuals with cystic fibrosis (CF) and their families experience significant emotional morbidity. In addition to distress, worry, and grief, high rates of clinically significant symptoms of depression and anxiety have been found in both individuals with CF and parents. These disorders have a major impact on the person's functioning, and that of their family, and adversely impact the capacity to cope with the burden of CF and adhere to prescribed treatments. Despite growing recognition that mental health care is an essential component of comprehensive CF care, evidence suggests many patients and their families do not receive needed support and mental health interventions. Clinical practice guidelines for screening and treating depression and anxiety in individuals with CF have been developed by The Cystic Fibrosis Foundation and the European Cystic Fibrosis Society in response to this need. This review highlights that the optimum care for individuals with CF and their families incorporates mental health in routine CF care. Addressing mental health could substantially improve physical and mental health outcomes and the functioning of individuals with CF and their families. Pediatr Pulmonol. 2016;51:S71–S78.

AB - Research shows that individuals with cystic fibrosis (CF) and their families experience significant emotional morbidity. In addition to distress, worry, and grief, high rates of clinically significant symptoms of depression and anxiety have been found in both individuals with CF and parents. These disorders have a major impact on the person's functioning, and that of their family, and adversely impact the capacity to cope with the burden of CF and adhere to prescribed treatments. Despite growing recognition that mental health care is an essential component of comprehensive CF care, evidence suggests many patients and their families do not receive needed support and mental health interventions. Clinical practice guidelines for screening and treating depression and anxiety in individuals with CF have been developed by The Cystic Fibrosis Foundation and the European Cystic Fibrosis Society in response to this need. This review highlights that the optimum care for individuals with CF and their families incorporates mental health in routine CF care. Addressing mental health could substantially improve physical and mental health outcomes and the functioning of individuals with CF and their families. Pediatr Pulmonol. 2016;51:S71–S78.

KW - anxiety

KW - cystic fibrosis

KW - depression

KW - screening

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=84988521783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988521783&partnerID=8YFLogxK

U2 - 10.1002/ppul.23522

DO - 10.1002/ppul.23522

M3 - Review article

C2 - 27662107

AN - SCOPUS:84988521783

VL - 51

SP - S71-S78

JO - Pediatric Pulmonology

JF - Pediatric Pulmonology

SN - 8755-6863

ER -